⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 2, 2010Alimentary Pharmacology & Therapeutics

The development and validation of a Nocturnal Gastro‐oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults

Brennan Spiegel Lewis R. Roberts Reema Mody Gale Harding Smita Kothari‐Talwar Peter J. Kahrilas M. L. Camilleri Omar Dabbous Dennis A. Revicki

View at Publisher

Ask AI

Bookmark

Share

Abstract

The results support the reliability and validity of the N-GSSIQ as a measure of severity, morning impact and concern about nocturnal GERD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Spiegel et al. (2010) studied this question.

synapsesocial.com/papers/69d94d93c7f0c3ae80a3cbf8 https://doi.org/10.1111/j.1365-2036.2010.04385.x

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Consequences of frequent nocturnal gastro‐oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivityOriginal Research · 2007 · 97 citations
2Comparison of the effects of immediate‐release omeprazole oral suspension, delayed‐release lansoprazole capsules and delayed‐release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night‐time GERD symptomsOriginal Research · 2007 · 93 citations
3Sleep‐related gastro‐oesophageal reflux: provocation with a late evening meal and treatment with acid suppressionRCT · 1998 · 57 citations
4Primary-Care Physicians' Perceptions and Practices on the Management of GERD: Results of a National SurveyRetrospective Study · 2005 · 71 citations
5Gastrointestinal Quality of Life Index: Development, validation and application of a new instrumentDiagnostic Study · 1995 · 1,292 citations

More related papers

Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease2003
Coefficient Alpha and the Internal Structure of Tests1951
Effect Sizes for Interpreting Changes in Health Status1989

More from Alimentary Pharmacology & Therapeutics

Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC , Warfarin and Non‐Anticoagulated PatientsThu,
Meta‐Analysis: Safety and Effectiveness of Advanced Therapies in Inflammatory Bowel Disease Patients With Concomitant Primary Sclerosing CholangitisWed,